1. Home
  2. CDNL vs PCRX Comparison

CDNL vs PCRX Comparison

Compare CDNL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDNL

Cardinal Infrastructure Group Inc. Class A Common Stock

N/A

Current Price

$52.07

Market Cap

980.9M

Sector

N/A

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.43

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNL
PCRX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.9M
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
CDNL
PCRX
Price
$52.07
$23.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$38.00
$30.25
AVG Volume (30 Days)
459.0K
517.6K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
$50.30
$6.78
Revenue Next Year
$8.41
$8.54
P/E Ratio
$0.01
$338.29
Revenue Growth
N/A
26.04
52 Week Low
$21.98
$18.80
52 Week High
$63.18
$27.64

Technical Indicators

Market Signals
Indicator
CDNL
PCRX
Relative Strength Index (RSI) 51.89 48.10
Support Level $46.60 $22.06
Resistance Level $54.55 $24.20
Average True Range (ATR) 4.86 1.04
MACD -0.62 0.05
Stochastic Oscillator 32.09 44.31

Price Performance

Historical Comparison
CDNL
PCRX

About CDNL Cardinal Infrastructure Group Inc. Class A Common Stock

Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. Its operations leverage a large highly skilled workforce and a fleet of specialized equipment to deliver wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: